Cargando…
Advances in breast cancer screening modalities and status of global screening programs
Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward trend has been predicted in the coming decades. Screening in selected targeted populations, which is effective in reducing cancer‐related mortality, has been widely implemented in many countries. This review summar...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215717/ https://www.ncbi.nlm.nih.gov/pubmed/35774423 http://dx.doi.org/10.1002/cdt3.21 |
_version_ | 1784731268495179776 |
---|---|
author | Luo, Chenyu Wang, Le Zhang, Yuhan Lu, Ming Lu, Bin Cai, Jie Chen, Hongda Dai, Min |
author_facet | Luo, Chenyu Wang, Le Zhang, Yuhan Lu, Ming Lu, Bin Cai, Jie Chen, Hongda Dai, Min |
author_sort | Luo, Chenyu |
collection | PubMed |
description | Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward trend has been predicted in the coming decades. Screening in selected targeted populations, which is effective in reducing cancer‐related mortality, has been widely implemented in many countries. This review summarizes the advances in BC screening techniques, organized or opportunistic BC screening programs across different countries, and screening modalities recommended by different academic authorities. Mammography is the most widely used and effective technique for BC screening. Other complementary techniques include ultrasound, clinical breast examination, and magnetic resonance imaging. Novel screening tests, including digital breast tomosynthesis and liquid biopsies, are still under development. Globally, the implementation status of BC screening programs is uneven, which is reflected by differences in screening modes, techniques, and population coverage. The recommended optimal screening strategies varied according to the authoritative guidelines. The effectiveness of current screening programs is influenced by several factors, including low detection rate, high false‐positive rate, and unsatisfactory coverage and uptake rates. Exploration of accurate BC risk prediction models and the development of risk‐stratified screening strategies are highly warranted in future research. |
format | Online Article Text |
id | pubmed-9215717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92157172022-06-29 Advances in breast cancer screening modalities and status of global screening programs Luo, Chenyu Wang, Le Zhang, Yuhan Lu, Ming Lu, Bin Cai, Jie Chen, Hongda Dai, Min Chronic Dis Transl Med Reviews Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward trend has been predicted in the coming decades. Screening in selected targeted populations, which is effective in reducing cancer‐related mortality, has been widely implemented in many countries. This review summarizes the advances in BC screening techniques, organized or opportunistic BC screening programs across different countries, and screening modalities recommended by different academic authorities. Mammography is the most widely used and effective technique for BC screening. Other complementary techniques include ultrasound, clinical breast examination, and magnetic resonance imaging. Novel screening tests, including digital breast tomosynthesis and liquid biopsies, are still under development. Globally, the implementation status of BC screening programs is uneven, which is reflected by differences in screening modes, techniques, and population coverage. The recommended optimal screening strategies varied according to the authoritative guidelines. The effectiveness of current screening programs is influenced by several factors, including low detection rate, high false‐positive rate, and unsatisfactory coverage and uptake rates. Exploration of accurate BC risk prediction models and the development of risk‐stratified screening strategies are highly warranted in future research. John Wiley and Sons Inc. 2022-05-25 /pmc/articles/PMC9215717/ /pubmed/35774423 http://dx.doi.org/10.1002/cdt3.21 Text en © 2022 The Authors. Chronic Diseases and Translational Medicine published by John Wiley & Sons Ltd on behalf of Chinese Medical Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Reviews Luo, Chenyu Wang, Le Zhang, Yuhan Lu, Ming Lu, Bin Cai, Jie Chen, Hongda Dai, Min Advances in breast cancer screening modalities and status of global screening programs |
title | Advances in breast cancer screening modalities and status of global screening programs |
title_full | Advances in breast cancer screening modalities and status of global screening programs |
title_fullStr | Advances in breast cancer screening modalities and status of global screening programs |
title_full_unstemmed | Advances in breast cancer screening modalities and status of global screening programs |
title_short | Advances in breast cancer screening modalities and status of global screening programs |
title_sort | advances in breast cancer screening modalities and status of global screening programs |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215717/ https://www.ncbi.nlm.nih.gov/pubmed/35774423 http://dx.doi.org/10.1002/cdt3.21 |
work_keys_str_mv | AT luochenyu advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms AT wangle advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms AT zhangyuhan advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms AT luming advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms AT lubin advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms AT caijie advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms AT chenhongda advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms AT daimin advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms |